drugset / Trial / NCT01827618
Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate the effects of rapamycin directly on bladder tumors and the effects of rapamycin on the immune system of patients with bladder cancer.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 3 mg | Oral |